The whey acidic protein (WAP) is a major milk protein in mice, rats, and rabbits but has not been found in milk of livestock including swine. To determine whether mammary gland regulatory elements from the WAP gene function across species boundaries and whether it is possible to qualitatively alter milk protein composition, we introduced the mouse WAP gene into the genome of swine. Three lines of transgenic swine were analyzed, and mouse WAP was detected in milk from all lactating females at concentrations of about 1 g/liter; these levels are similar to those found in mouse milk.
ABSTRACT
The whey acidic protein (WAP) is a major milk protein in mice, rats, and rabbits but has not been found in milk of livestock including swine. To determine whether mammary gland regulatory elements from the WAP gene function across species boundaries and whether it is possible to qualitatively alter milk protein composition, we introduced the mouse WAP gene into the genome of swine. Three lines of transgenic swine were analyzed, and mouse WAP was detected in milk from all lactating females at concentrations of about 1 g/liter; these levels are similar to those found in mouse milk.
Expression of the corresponding RNA was specific to the mammary gland. Our results suggest that the molecular basis of mammary-specific gene expression is conserved between swine and mouse. In addition the WAP gene must share, with other milk protein genes, elements that target gene expression to the mammary gland. Mouse WAP accounted for about 3% of the total milk proteins in transgenic pigs, thus demonstrating that it is possible to produce high levels of a foreign protein in milk of farm animals.
Milk protein genes are transcribed in the mammary gland of lactating animals, and the encoded proteins are secreted in large quantities into milk. The whey acidic protein (WAP) is an abundant milk protein in mice (1, 2) but has not been found in swine or other livestock. Expression of the WAP gene is confined to the mammary gland (2, 3) and is under the control of steroid and peptide hormones as well as other developmental signals during pregnancy (4) (5) (6) .
By targeting synthesis of foreign proteins to the mammary gland of transgenic animals, it should be possible to produce valuable proteins on a large scale in milk (7, 8) . The MATERIALS AND METHODS Production of Transgenic Pigs. Ovulation control and egg recovery were performed as described (14) . Briefly, the time of ovulation of sexually mature gilts was controlled by feeding 15 mg of Altrenogest (R-2267, 17-allyl-hydroxyestra-4,9,11-trien-3-one, Roussel-Uclaf) daily for [5] [6] [7] [8] [9] days, beginning on day 12 of each oviduct. Recovered ova were immediately transferred into BMOC buffer (16) prior to microinjection and maintained at 38TC. Pig ova are optically opaque and, as a consequence, their nuclear structures are not visible. However, centrifuging ova at =15,000 X g for 3-8 min displaces the opaque material in the cytoplasm, thereby allowing the nuclear structures to be visualized (14) . Pig ova were centrifuged, and a pronucleus of one-celled ova or both nuclei of two-celled ova were injected with a TE solution (1 mM Tris HCl/0.1 mM EDTA, pH 7.2) containing =2 ng of a 7.2-kilobase (kb) EcoRI fragment per ,ul that contained the mouse WAP gene (10) . The fragment contained the entire transcribed region with its four exons, three introns, and 2.6-kb 5' and 1.6-kb 3' flanking sequences. Microinjections were performed with the aide of differential interference contrast optics at 200-fold magnification, essentially as described for mouse ova (17) .
Between 20 and 30 injected ova were deposited into the ampullar region of one oviduct of each recipient gilt whose reproduction cycle had been synchronized with Altrenogest (but not superovulated-i.e., not given PMSG) or whose estrous cycle naturally coincided with the desired stage. Some recipients also received 2-4 uninjected control ova to increase the likelihood of maintaining pregnancy in the event that a majority of the microinjected eggs failed to develop. Time between microinjection and embryo transfer was about 30 min.
To identify transgenic piglets, DNA from tail biopsies was prepared and analyzed for the mouse WAP gene by Southern blotting. Offspring in the F1 generation were analyzed by the polymerase chain reaction by using primers specific to the WAP gene.
Analysis of Mouse WAP. Milk whey proteins were separated under denaturing conditions in sodium dodecyl sulfate (SDS)/16% polyacrylamide gels and either stained with Coomassie Blue or transferred to nitrocellulose filters. After transfer the membrane was incubated overnight in TBS (20 mM Tris'HCI, pH 7.5/500 mM NaCl) containing 3% gelatin and then was washed in TTBS (TBS containing 0.05% Tween 20) . The membrane was then probed for 90 min with a 1:200 dilution of rabbit anti-WAP serum, followed by washing and incubation with alkaline phosphatase-conjugated goat antirabbit IgG in TBS containing 1% bovine serum albumin for 1 hr. The antibody-antigen complexes were stained with nitrobluetetrazolium and 5-bromo-4-chloro-3-indolyl phosphate in 100 mM Tris HCI, pH 9.5/100 mM NaCI/5 mM MgCI2-Isolation of RNA and Northern Blot Analysis. During necropsy, tissues were immediately placed in liquid nitrogen and stored at -80°C, and total RNA was isolated (18) . RNA samples containing 1 ul of ethidium bromide solution (1 mg/ml) were electrophoresed in 1.5% agarose/formaldehyde gels. The gels were blotted onto GeneScreenPlus nylon membranes, which were then probed with a randomly primed labeled 450-base-pair (bp) cDNA fragment that spanned the mouse WAP coding region.
RESULTS
The Mouse WAP Gene in Transgenic Swine. Eight-hundred and fifty ova were recovered and microinjected, of which two-thirds were at the one-cell stage of development. The injected DNA contained 7. Approximately 1% of the injected ova resulted in transgenic founders. From other transgenic pig projects using different gene constructs, the efficiency of producing founder pigs was similar (11) . In this study one pig was stillborn and one died shortly after birth. Such deaths are not uncommon in the pig industry, where neonate mortality is in the range of 15-20%. Lines from the three surviving pigs were established, and offspring were analyzed. Male founder 1301 was bred to three nontransgenic females; 4 of 32 offspring were transgenic, suggesting that he was mosaic for the WAP gene. Transgenic mouse breeding studies have estimated that about 30% of transgenic founders are germ-line mosaics (19) . Based on Southern blot analyses, this line contains -10 intact copies of the WAP gene in a head-to-tail arrangement at a single locus. Female founder 2202 carried =15 copies of the WAP gene. She was bred at 8 months of age; 4 of 9 offspring were transgenic. She was bred a second time and died of an unknown cause 4 days before anticipated parturition. The two transgenic daughters from her first litter were also bred, and after farrowing, milk and RNA were analyzed. Female founder 1302, carrying =10 copies of the WAP gene, was unsuccessfully bred three times. After the third failure, she was superovulated as a means of diagnosing the cause of her reproductive failures and to collect eggs if the cause did not involve ovarian disfunction. Twenty-eight ova were recovered and transferred to two recipients. From these, 20 piglets were born of which 8 were transgenic. Apparently not all of female founder 1302's eggs had been recovered because she subsequently gave birth to 9 piglets, 5 of which were transgenic.
Secretion of Mouse WAP into Pig Milk. Expression of the WAP transgene in transgenic pigs was evaluated by both protein and RNA analyses. Milk from female founder 2202 and her daughter 5403, from two daughters (5511 and 5701) of male founder 1301, and from female founder 1302, was analyzed for the presence of mouse WAP. Milk proteins were separated in SDS/polyacrylamide gels and either stained with Coomassie blue or blotted onto nitrocellulose membranes and analyzed with anti-mouse WAP antibodies. WAP has a molecular mass of about 14 kDa (Fig. 1A, lane 8 (Fig. 1A, lane 2) . A protein comigrating with mouse WAP was present in the milk of transgenic pigs (Fig. 1A, lanes 4-7) but not in milk from a nontransgenic control pig (Fig. 1A, lane 3) . In addition, a 14-kDa protein in milk from transgenic, but not from nontransgenic, pigs reacted strongly with anti-mouse WAP antibodies (Fig. 1B) (Fig. 2) . Whey samples were separated in SDS/ polyacrylamide gels and either stained ( Fig. 2A) or analyzed with anti-WAP antibodies (Fig. 2B) . Constant levels of WAP were found over a 26-day period. This suggests that, at least over this period oftime, the WAP transgene was coordinately regulated with other pig milk protein genes.
Expression of Mouse WAP RNA in Pigs. To correlate the level of WAP in milk with the corresponding RNA in mammary tissue, founder female 2202 was biopsied 11 days postpartum, and mammary RNA was analyzed with a mousespecific WAP cDNA. An RNA of about 600 nucleotides hybridized with the WAP probe (Fig. 3, lanes b and c) , confirming mouse WAP gene expression in the mammary glands oftransgenic pigs. Furthermore, the RNA levels in pig 2202 and mouse were similar; this agrees with the WAP levels about 10-20 nucleotides shorter than its counterpart in mice (Fig. 3) . Since the protein coding region was intact, the smaller size may be due to differences in polyadenylylation. RNA from a nontransgenic pig did not hybridize with the WAP probe (Fig. 3, lane a) , verifying the absence of an endogenous WAP RNA in the pig mammary gland.
In lactating mice the WAP gene is expressed almost exclusively in the mammary gland with levels in nonmammary tissues at least 4 orders of magnitude lower (5) . To test whether the 7.2-kb WAP transgene contained elements for stringent tissue specificity observed in mice, we analyzed tissues from lactating pigs from lines 2202 and 1301 for the presence of WAP RNA (Fig. 4) . To demonstrate potential WAP expression in nonmammary tissues, we exposed the RNA blot for 24 hr (Fig. 4 a and c) . The specificity of WAP hybridization and the quantity ofWAP RNA in the mammary gland were assessed in a 30-min exposure (Fig. 4b) . In animal 5701 (line 1301), WAP RNA was only found in the mammary gland (Fig. 4c) at a level similar to that seen in a 10-day lactating mouse. The sensitivity of the assay would have (Fig. 4a) (Fig. 4a) . Low-level expression in the salivary gland also has been described for other transgenes containing regulatory elements from milk protein genes (5, 20) . Although the salivary gland and mammary gland have similar developmental patterns in that they require interaction between epithelial and mesenchymal tissue for proper duct formation to occur (21, 22) , they are not considered closely related. In contrast, sebaceous glands have a common developmental origin to that of the mammary gland. However, no WAP transcripts were found in tissue taken from the vulva (Fig. 4) , which is rich in sebaceous glands. (24) , the rat WAP (25) and /-casein (26) genes, and several hybrid genes containing mammary regulatory elements (27) (28) (29) (30) (31) . However, the concentrations of the encoded proteins factor IX and a1-antitrypsin were only 25 pg/liter and 5 mg/liter, respectively (31) . With another transgene, this group produced human a1-antitrypsin in mouse milk at levels of more than 1 g/liter (20 The concentration of the transgene product produced in this study should be encouraging to those who envision using the mammary gland as a bioreactor for the production of foreign proteins as an economically viable alternative to existing tissue and microbial culture systems (7, 8) . Swine produce about 10 kg of milk per day (32) , and, based on the expression levels discussed here, it should be possible to produce the protein of interest at a rate of about 1 (20, 35) at levels similar to or exceeding those described here with swine. Experiments are in progress to determine whether the premature termination of lactation exhibited by some of the pigs is associated with mammary gene expression.
DISCUSSION
Note Added in Proof. We have generated transgenic mice with the 7.2-kb WAP transgene described in this paper and observed that some of the animals cannot maintain lactation (T. Burdon, R.J.W., and L.H., unpublished data).
